{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:35:35Z","timestamp":1787027735932,"version":"build-2736575974"},"reference-count":48,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Background\/Objectives: Colorectal cancer (CRC) is one of the most prevalent malignancies; this issue underlines the need for accurate molecular biomarkers for early detection and accurate prognosis. Circular RNAs (circRNAs) have recently emerged as very promising cancer biomarkers. The circular transcript of the chaperonin-containing TCP1 subunit 3 (CCT3) gene, namely circ-CCT3, is a significant oncogenic driver. In gastrointestinal malignancies, circ-CCT3 promotes tumor growth by sponging tumor-suppressor miRNAs. In this study, we examined whether circ-CCT3 expression can predict the prognosis of patients diagnosed with colorectal adenocarcinoma, the most frequent type of CRC. Methods: Total RNA was extracted from pulverized, fresh frozen colorectal tissues and reverse-transcribed. A previously developed, highly sensitive quantitative PCR (qPCR) assay was applied to determine circ-CCT3 expression in 216 primary colorectal adenocarcinoma tissue specimens and 86 paired normal colorectal tissues. Results: circ-CCT3 was significantly upregulated in colorectal adenocarcinoma tissues, in comparison to their non-cancerous tissue counterparts. Higher circ-CCT3 expression was associated with a poorer disease-free (DFS) and overall survival (OS) of colorectal adenocarcinoma patients. Interestingly, multivariate Cox regression showed that the prognostic value of circ-CCT3 expression regarding DFS was independent of other established prognosticators used in clinical practice, including TNM staging. Furthermore, the stratification of patients based on the TNM classification of the tumors revealed that increased circ-CCT3 levels predicted shorter DFS and OS intervals, especially in the subgroup of TNM stage II or III patients. Conclusions: Our study provides evidence that circ-CCT3 overexpression constitutes a promising molecular biomarker of poor prognosis in colorectal adenocarcinoma, independently predicting tumor recurrence.<\/jats:p>","DOI":"10.3390\/biomedicines13102432","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T11:42:49Z","timestamp":1759750969000},"page":"2432","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Retrospective Study in Colorectal Adenocarcinoma Uncovers the Potential of Circ-CCT3 as a Predictor of Tumor Recurrence"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4267-6813","authenticated-orcid":false,"given":"Panagiotis","family":"Kokoropoulos","sequence":"first","affiliation":[{"name":"Fourth Department of Surgery, University General Hospital \u201cAttikon\u201d, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4725-648X","authenticated-orcid":false,"given":"Spyridon","family":"Christodoulou","sequence":"additional","affiliation":[{"name":"Fourth Department of Surgery, University General Hospital \u201cAttikon\u201d, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3920-2278","authenticated-orcid":false,"given":"Panagiotis","family":"Tsiakanikas","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, Panepistimiopolis, 15771 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthimios","family":"Poulios","sequence":"additional","affiliation":[{"name":"Fourth Department of Surgery, University General Hospital \u201cAttikon\u201d, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5859-7917","authenticated-orcid":false,"given":"Panteleimon","family":"Vassiliu","sequence":"additional","affiliation":[{"name":"Fourth Department of Surgery, University General Hospital \u201cAttikon\u201d, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9935-8461","authenticated-orcid":false,"given":"Christos K.","family":"Kontos","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, Panepistimiopolis, 15771 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0355-0417","authenticated-orcid":false,"given":"Nikolaos","family":"Arkadopoulos","sequence":"additional","affiliation":[{"name":"Fourth Department of Surgery, University General Hospital \u201cAttikon\u201d, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S2468-1253(23)00366-7","article-title":"Global, regional, and national lifetime risks of developing and dying from gastrointestinal cancers in 185 countries: A population-based systematic analysis of GLOBOCAN","volume":"9","author":"Wang","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","article-title":"Global burden of colorectal cancer in 2020 and 2040: Incidence and mortality estimates from GLOBOCAN","volume":"72","author":"Morgan","year":"2023","journal-title":"Gut"},{"key":"ref_3","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","article-title":"A genetic model for colorectal tumorigenesis","volume":"61","author":"Fearon","year":"1990","journal-title":"Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.5306\/wjco.v15.i9.1136","article-title":"Colorectal cancer: Recent advances in management and treatment","volume":"15","author":"Fadlallah","year":"2024","journal-title":"World J. Clin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Adebayo, A.S., Agbaje, K., Adesina, S.K., and Olajubutu, O. (2023). Colorectal Cancer: Disease Process, Current Treatment Options, and Future Perspectives. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15112620"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.cgh.2022.08.046","article-title":"Initial Impact of National CRC Screening on Incidence and Advanced Colorectal Cancer","volume":"21","author":"Krul","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Koncina, E., Haan, S., Rauh, S., and Letellier, E. (2020). Prognostic and Predictive Molecular Biomarkers for Colorectal Cancer: Updates and Challenges. Cancers, 12.","DOI":"10.3390\/cancers12020319"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1200\/JCO.2016.71.9807","article-title":"Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology","volume":"35","author":"Sepulveda","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Liu, C., Jin, M., Wang, S., Han, W., Zhao, Q., Wang, Y., Xu, C., Diao, L., Yin, Y., and Peng, C. (2023). Pathway and mechanism of tubulin folding mediated by TRiC\/CCT along its ATPase cycle revealed using cryo-EM. Commun. Biol., 6.","DOI":"10.1038\/s42003-023-04915-x"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Ghozlan, H., Cox, A., Nierenberg, D., King, S., and Khaled, A.R. (2022). The TRiCky Business of Protein Folding in Health and Disease. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.906530"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Ma, J., Song, P., Liu, X., Ma, C., Zheng, M., Ren, X., Wang, R., Liu, W., Lu, Z., and Li, J. (2022). Insights into the roles and driving forces of CCT3 in human tumors. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.1005855"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.1111\/bph.16494","article-title":"Repurposing cyclovirobuxine D as a novel inhibitor of colorectal cancer progression via modulating the CCT3\/YAP axis","volume":"181","author":"Liu","year":"2024","journal-title":"Br. J. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1074\/mcp.M800428-MCP200","article-title":"Discovery and scoring of protein interaction subnetworks discriminative of late stage human colon cancer","volume":"8","author":"Nibbe","year":"2009","journal-title":"Mol. Cell Proteomics"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12943-020-01286-3","article-title":"Circular RNA: Metabolism, functions and interactions with proteins","volume":"19","author":"Zhou","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41419-023-05881-2","article-title":"CircRNAs in colorectal cancer: Potential biomarkers and therapeutic targets","volume":"14","author":"Zhang","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Liu, W., Lu, Y., Yan, X., Lu, Q., Sun, Y., Wan, X., Li, Y., Zhao, J., Li, Y., and Jiang, G. (2022). Current understanding on the role of CCT3 in cancer research. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.961733"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1097\/CAD.0000000000001166","article-title":"Circular RNA circ-CCT3 promotes bortezomib resistance in multiple myeloma via modulating miR-223-3p\/BRD4 axis","volume":"33","author":"Liu","year":"2022","journal-title":"Anticancer. Drugs"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2204772","DOI":"10.1080\/15592294.2023.2204772","article-title":"m(6)A-modification regulated circ-CCT3 acts as the sponge of miR-378a-3p to promote hepatocellular carcinoma progression","volume":"18","author":"Liu","year":"2023","journal-title":"Epigenetics"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3892\/mmr.2021.12014","article-title":"Circular RNA circ-CCT3 promotes hepatocellular carcinoma progression by regulating the miR-1287-5p\/TEAD1\/PTCH1\/LOX axis","volume":"23","author":"Lin","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"ref_21","first-page":"7020774","article-title":"circCCT3 Enhances Invasion and Epithelial-Mesenchymal Transition (EMT) of Non-Small-Cell Lung Cancer (NSCLC) via the miR-107\/Wnt\/FGF7 Axis","volume":"2022","author":"Li","year":"2022","journal-title":"J. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.5152\/balkanmedj.2021.21145","article-title":"CircCCT3 Acts as a Sponge of miR-613 to Promote Tumor Growth of Pancreatic Cancer Through Regulating VEGFA\/VEGFR2 Signaling","volume":"38","author":"Hou","year":"2021","journal-title":"Balkan Med. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1002\/hem3.34","article-title":"Exploring the molecular biomarker utility of circCCT3 in multiple myeloma: A favorable prognostic indicator, particularly for R-ISS II patients","volume":"8","author":"Papatsirou","year":"2024","journal-title":"Hemasphere"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1089\/dna.2019.5139","article-title":"circCCT3 Modulates Vascular Endothelial Growth Factor A and Wnt Signaling to Enhance Colorectal Cancer Metastasis Through Sponging miR-613","volume":"39","author":"Li","year":"2020","journal-title":"DNA Cell Biol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Luo, L., Xie, Q., Wu, Y., Li, P., Qin, F., Liao, D., and Wang, K. (2023). Circular RNA CCT3 is a unique molecular marker in bladder cancer. BMC Cancer, 23.","DOI":"10.1186\/s12885-023-11510-0"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"ref_27","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3892\/ol.2023.13816","article-title":"Molecular subtyping in colorectal cancer: A bridge to personalized therapy (Review)","volume":"25","author":"Wang","year":"2023","journal-title":"Oncol. Lett."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"808","DOI":"10.4251\/wjgo.v12.i8.808","article-title":"Early stage colon cancer: Current treatment standards, evolving paradigms, and future directions","volume":"12","author":"Chakrabarti","year":"2020","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.gastro.2014.09.041","article-title":"Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes","volume":"148","author":"Sinicrope","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1158\/1078-0432.CCR-16-2541","article-title":"Circular RNA ciRS-7-A Promising Prognostic Biomarker and a Potential Therapeutic Target in Colorectal Cancer","volume":"23","author":"Weng","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clinbiochem.2019.10.012","article-title":"Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer","volume":"74","author":"Lin","year":"2019","journal-title":"Clin. Biochem."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Kokoropoulos, P., Christodoulou, S., Tsiakanikas, P., Vassiliu, P., Kontos, C.K., and Arkadopoulos, N. (2025). Overexpression of Circular PRMT1 Transcripts in Colorectal Adenocarcinoma Predicts Recurrence and Poor Overall Survival. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26146683"},{"key":"ref_34","first-page":"661","article-title":"Diagnostic and therapeutic biomarkers in colorectal cancer: A review","volume":"12","author":"Coutinho","year":"2022","journal-title":"Am. J. Cancer Res."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Zamanian, M.Y., Darmadi, D., Darabi, R., Fanoukh Aboqader Al-Aouadi, R., Sadeghi Ivraghi, M., and K\u00fcpeli Akkol, E. (2025). Biomarkers for colorectal cancer detection: An insight into colorectal cancer and FDA-approved biomarkers. Bioimpacts, 15.","DOI":"10.34172\/bi.31211"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Tan, J.N., Yu, J.H., Hou, D., Xie, Y.Q., Lai, D.M., Zheng, F., Yang, B., Zeng, J.T., Chen, Y., and Lu, S.H. (2025). Extracellular Vesicle-Packaged circTAX1BP1 from Cancer-Associated Fibroblasts Regulates RNA m6A Modification through Lactylation of VIRMA in Colorectal Cancer Cells. Adv. Sci., e14008.","DOI":"10.1002\/advs.202514008"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"149684","DOI":"10.1016\/j.gene.2025.149684","article-title":"Research progress of circular RNA and N6-methyladenosine modification in colorectal cancer","volume":"967","author":"Xu","year":"2025","journal-title":"Gene"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.clinbiochem.2016.11.034","article-title":"Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma","volume":"50","author":"Kerimis","year":"2017","journal-title":"Clin. Biochem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.canlet.2012.11.036","article-title":"Kallikrein-related peptidase 4 (KLK4) mRNA predicts short-term relapse in colorectal adenocarcinoma patients","volume":"330","author":"Kontos","year":"2013","journal-title":"Cancer Lett."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4174\/astr.2014.86.3.143","article-title":"Predictive factors and the prognosis of recurrence of colorectal cancer within 2 years after curative resection","volume":"86","author":"Ryuk","year":"2014","journal-title":"Ann. Surg. Treat. Res."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Abe, S., Kawai, K., Nozawa, H., Sasaki, K., Murono, K., Emoto, S., Ozawa, T., Yokoyama, Y., Nagai, Y., and Anzai, H. (2022). Clinical impact of primary tumor sidedness and sex on unresectable post-recurrence survival in resected pathological stage II\u2013III colorectal cancers: A nationwide multicenter retrospective study. BMC Cancer, 22.","DOI":"10.1186\/s12885-022-09615-z"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1200\/JCO.2007.15.8261","article-title":"Survival following recurrence in stage II and III colon cancer: Findings from the ACCENT data set","volume":"26","author":"Campbell","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Nikolic, N., Radosavljevic, D., Gavrilovic, D., Nikolic, V., Stanic, N., Spasic, J., Cacev, T., Castellvi-Bel, S., Cavic, M., and Jankovic, G. (2021). Prognostic Factors for Post-Recurrence Survival in Stage II and III Colorectal Carcinoma Patients. Medicina, 57.","DOI":"10.3390\/medicina57101108"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12957-023-03015-8","article-title":"Influence of the initial recurrence site on prognosis after radical surgery for colorectal cancer: A retrospective cohort study","volume":"21","author":"Pu","year":"2023","journal-title":"World J. Surg. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.5306\/wjco.v12.i11.1000","article-title":"Consensus molecular subtypes of colorectal cancer in clinical practice: A translational approach","volume":"12","author":"Valenzuela","year":"2021","journal-title":"World J. Clin. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/modpathol.2017.46","article-title":"Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016","volume":"30","author":"Lugli","year":"2017","journal-title":"Mod. Pathol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e14232","DOI":"10.1002\/advs.202414232","article-title":"Tailoring a Functional Synthetic Microbial Community Alleviates Fusobacterium nucleatum-infected Colorectal Cancer via Ecological Control","volume":"12","author":"Zhou","year":"2025","journal-title":"Adv. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Kanda, S., Watanabe, K., Nakamura, S., and Narimatsu, H. (2025). Association between socioeconomic background and cancer: An ecological study using cancer registry and various community socioeconomic status indicators in Kanagawa, Japan. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0326895"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/10\/2432\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T12:19:02Z","timestamp":1759753142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/10\/2432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":48,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["biomedicines13102432"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines13102432","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]}}}